Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patient expectations

Michel Dubery joins inVentiv Health Communications

Will lead European comms division

- PMLiVE

FDA turns down Novo Nordisk’s Tresiba and Ryzodeg

Decision could delay the US launch of the diabetes drugs by two years or more

- PMLiVE

Lilly abandons tabalumab for rheumatoid arthritis

Decision based on lack of efficacy in late-stage trials

EU flag

Five pharma companies begin antibiotic research programme

Sanofi, GSK and AstraZeneca among the collaborators on European projects

IBM Watson makes its clinical decision support debut

Supercomputer-powered tool could be a breakthrough in evidence-based medicine

- PMLiVE

Ireland’s MedMedia Campaign agency joins Indigenus

Dublin-based independent is newest partner for global network

- PMLiVE

Celgene gets US green light for blockbuster candidate Pomalyst

FDA approval to treat multiple myeloma

ABPI and Luther Pendragon parted ways over tobacco lobbying

The Lancet calls on other healthcare organisations to sever ties with the agency

- PMLiVE

Chugai appoints Ruth Currie as MD of its UK business

She replaces John Halls, who has been promoted

- PMLiVE

Publicis merges Digitas and LBi competencies to form leading global network

Publicis Groupe to combine digital strengths by forming DigitasLBi

Digital reach is ‘gold dust’ for pharma

How companies perform online will be a key differentiating factor, says Merck & Co's Gerhard Arnhofer

- PMLiVE

Merck blocks Mylan’s generic Zetia and Vytorin after appeal

Keeps patents of cholesterol medicines protected until April 2017

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links